声动力疗法促进颈股动脉斑块管腔获得:单中心前瞻性临床研究
单中心前瞻性先导性临床研究纳入24例外周动脉疾病患者,均接受优化口服药物联合单次华卟啉钠介导的声动力疗法(SDT)。第4周斑块处管腔直径狭窄率较基线下降(50.1±1.2)% vs(57.2±1.1)%,P<0.001,%Δ为(12.32±1.05)%;第1周亦下降,%Δ为(9.61±0.85)%。亚组分析显示疗效与他汀使用无关,颈动脉与股动脉均有效,低回声及混合回声斑块疗效更显著,轻中重度狭窄均有效。
要点
- SDT单次治疗后1周和4周斑块处管腔直径狭窄率均较基线显著下降。
- 疗效不受入组前他汀使用影响,颈动脉与股动脉斑块均可见管腔获得。
- 低回声及混合回声斑块疗效更显著,轻中重度狭窄均有效。
核心结论
- 在本单中心先导性研究中,SDT在轻、中、重度狭窄及低回声/混合回声斑块中均有一定疗效,可快速促进颈/股动脉粥样硬化斑块处的管腔获得。
研究设计与样本
- 单中心前瞻性先导性临床研究,纳入2016年2至9月哈尔滨医科大学附属第一医院心内科门诊的外周动脉疾病患者24例,年龄(70.7±2.2)岁,男性20例(83%)。
- 全部患者给予优化口服药物治疗并接受SDT治疗1次,治疗前及治疗后1、4周行彩色多普勒超声评估。
主要发现
- 第4周斑块处管腔直径狭窄率较基线下降(50.1±1.2)% vs(57.2±1.1)%,P<0.001,%Δ为(12.32±1.05)%。
- 第1周斑块处管腔直径狭窄率较基线下降(51.7±1.2)% vs(57.2±1.1)%,P<0.001,%Δ为(9.61±0.85)%。
- 亚组分析显示SDT对狭窄率变化的影响与入组前是否使用他汀类药物无关。
- SDT均可减轻颈动脉与股动脉斑块处管腔直径狭窄率,对低回声及混合回声斑块疗效更显著。
- 对于不同狭窄程度的斑块,SDT均能有效降低斑块处管腔直径狭窄率(P均<0.05)。
临床怎么用
- 对于颈/股动脉粥样硬化斑块患者,在优化口服药物治疗基础上,可考虑单次SDT以快速促进管腔获得。
- 低回声及混合回声斑块、轻中重度狭窄患者均可能从SDT中获益,选择患者时可不拘于他汀使用状态。
局限性
- 本研究为单中心先导性研究,样本量较小(24例),结论需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To preliminarily evaluate the lumen gain of sonodynamic therapy (SDT) mediated by sinoporphyrin sodium at carotid and femoral atherosclerotic plaque sites, and to assess whether concomitant statin use, lesion location, plaque echogenicity/type, and baseline stenosis severity modify the therapeutic response. Methods: This single-center, prospective, exploratory pilot clinical study enrolled patients with peripheral artery disease who attended the outpatient cardiology clinic of the First Affiliated Hospital of Harbin Medical University between February and September 2016. All enrolled patients received optimized oral medical therapy in combination with a single session of SDT. Vascular evaluation was performed using color Doppler ultrasound before treatment and 1 and 4 weeks after treatment. The primary efficacy endpoint was the percent change from baseline in luminal diameter stenosis at the site of the atherosclerotic plaque (%Δ) at week 4, while the secondary efficacy endpoint was %Δ at week 1. Subgroup analyses were conducted according to prior statin use, plaque location, plaque characteristics, and baseline degree of luminal stenosis. Results: A total of 24 patients, aged (70.7±2.2) years were enrolled. There were 20 (83%) males. Compared to baseline, luminal diameter stenosis at the plaque site reduced by week 4 ((50.1±1.2)% vs. (57.2±1.1)%,P<0.001), %Δ was(12.32±1.05)%; and luminal diameter stenosis also reduced by week 1 ((51.7±1.2)% vs. (57.2±1.1)%,P<0.001)), %Δ was(9.61±0.85)%. In subgroup analyses, the treatment effect on diameter stenosis was independent of prior statin use; SDT reduced stenosis in both carotid and femoral plaques; with superior efficacy observed in hypoechoic and mixed-echo plaques; and efficacy was observed across mild, moderate, and severe baseline stenosis categories (all P<0.05). Conclusion: In this single-center pilot study, SDT demonstrates therapeutic efficacy across mild, moderate, and severe stenoses, as well as in hypoechoic and mixed-echo plaques, showing potential to rapidly promote luminal gain at carotid and femoral atherosclerotic plaque sites. 目的: 初步评估华卟啉钠介导的声动力疗法(SDT)对颈/股动脉粥样硬化斑块处管腔获得的促进作用,以及他汀类药物、斑块部位、斑块类型和管腔狭窄程度对SDT疗效的影响。 方法: 本研究为单中心前瞻性先导性临床研究。纳入于2016年2至9月在哈尔滨医科大学附属第一医院心内科门诊就诊的外周动脉疾病患者。患者入组后全部给予优化口服药物治疗,予SDT治疗1次。患者于治疗前及治疗后1、4周使用彩色多普勒超声进行评估。主要疗效终点为第4周粥样硬化斑块处血管管腔直径狭窄率较基线的变化百分比(%Δ);次要疗效终点为第1周的%Δ。根据入组前是否使用他汀类药物、斑块部位、斑块类型及管腔狭窄程度分别进行亚组分析。 结果: 共纳入24例患者,年龄为(70.7±2.2)岁,其中男性20例(83%)。SDT治疗后第4周斑块处血管管腔直径狭窄率较基线下降[(50.1±1.2)%比(57.2±1.1)%,P<0.001],%Δ为(12.32±1.05)%;治疗第1周斑块处血管管腔直径狭窄率较基线下降[(51.7±1.2)%比(57.2±1.1)%,P<0.001],%Δ为(9.61±0.85)%。亚组分析结果显示,SDT对斑块狭窄处管腔狭窄率变化的影响与患者入组前是否使用他汀类药物无关;SDT均可减轻颈动脉与股动脉斑块处血管管腔直径狭窄率;对于低回声及混合回声斑块疗效更显著;对于不同狭窄程度的斑块,SDT均能有效降低斑块处管腔直径狭窄率(P均<0.05)。 结论: 在本单中心先导性研究中,SDT在轻、中、重度狭窄及低回声/混合回声斑块中均有一定疗效,可快速促进颈/股动脉粥样硬化斑块处的管腔获得。.
引用
- Wang Y, Sun YH, Liu Y, et al. [Sonodynamic therapy promotes luminal gain in carotid and femoral atherosclerotic plaques: a single-center prospective clinical study]. Zhonghua Xin Xue Guan Bing Za Zhi. 2025. PMID: 41287291. doi:10.3760/cma.j.cn112148-20250721-00519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。